Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. - Test2 - elhamkhani - TriplyDB

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

http://www.wikidata.org/entity/Q37976341

about

Obesity, fatty liver disease and intestinal microbiota Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells.Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents.Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.Pediatric Non-Alcoholic Fatty Liver Disease Developmental origins of nonalcoholic fatty liver disease Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study.SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids.Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.Management of pediatric and adolescent type 2 diabetes Pediatric non-alcoholic fatty liver disease: an increasing public health issue.Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH.Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert review.Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice.Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children?Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents.FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice.Nuclear Receptors: Opening Up New Avenues of Pediatric Fatty Liver Research Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease

P2860

Q26997784-538EA206-2DCC-4E79-B21B-31C60981DE58 Q30440631-3A63705D-084F-4D7E-B8A7-6D1D416B2271 Q33593809-197033D2-2A3E-47DE-A6DC-068C73DF4D3C Q33632921-442FD02A-61A6-4F94-8D2D-D01C70E08D32 Q33714116-04871159-5BCE-4969-AFEC-E2F677F4EEE4 Q33831717-F03A0C27-3755-4E32-A05D-B037062BB9CE Q33844787-38E78961-8612-4CBB-ADD4-BA83A61436E0 Q34191208-61DF6419-EE37-4EFA-B461-C9F0858A3454 Q34636684-EDCC985E-05BE-4FCC-A690-9453AD0D9AFE Q34685694-048F509E-8C8F-4913-AC2E-51FF6FA9B67A Q35084719-B42F2931-B1C8-49EB-B34D-60798C7BA035 Q35088371-34CBDF40-8402-4F93-ACA0-FFA83842A453 Q35801157-2F54D13C-9EA7-4DD9-B8AA-259D60A7C75C Q35927155-A58C3604-D252-4A2B-A620-714059583880 Q36054281-5BF30511-11C3-46C7-8178-C13935DE847A Q36387273-1C6C098D-E159-424A-A9DF-595D891D9330 Q36764809-DB9E9D3F-2F9E-49A9-853F-354931D81B2A Q37285253-D8AFDEAA-CB43-4E56-82E7-C8E90C2C9BC6 Q37292261-EA43518C-FA75-4491-BDC8-CBC0BE3D215C Q37592952-7F484EA1-7D2F-4722-B28C-B8B4C0D88289 Q38072280-4652FAF1-4857-494F-950F-97ED885CA223 Q38083661-FE7BF0A3-6615-4B61-8D45-C036185A6FD2 Q38144150-A30FCD6D-D2EF-48EC-91AD-52F71E33FE1D Q38249022-6C7A2263-D3CD-4EE0-AC74-66FD5A7F4B42 Q38336510-3E22A9A7-C5E4-4F52-891D-4C899FAC41BE Q38606360-48942012-9506-41F7-A293-8E58BB3A13C1 Q41158897-48BA6E67-2D68-476A-8500-E34EC23271B6 Q43529289-ABEDC0F3-A7EF-4D0D-9330-1EAB884496A1 Q44206097-76270DD6-87F1-4148-B87B-5D1447191B43 Q48865521-6F15C216-DC18-4B24-BA2E-285B31CD1281 Q51265948-06404BE2-25AE-42BE-87E7-D916DF06997C Q51329807-658D1A2E-0333-4F20-AE8D-73807A317DD0 Q53467119-F2B2DF5F-8FF8-418E-A313-2376C7AB3632 Q57055601-00166DE0-1364-4FBA-BFFB-2645A4B5EA5A Q57803934-C55FC522-FD3C-41E3-9112-244013D681E0

P2860

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

http://www.wikidata.org/entity/Q37976341

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

@en

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

@nl

type

label

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

@en

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

@nl

prefLabel

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

@en

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

@nl

P1433

Q37976341-B0C88AE9-A996-4220-AE00-6DAA4525CB75

P1476

Q37976341-E8092FB5-9D7F-4BBB-BFDB-7E05D62FBC3F

P2093

Q37976341-2096ADDB-59B8-47DB-A92F-78D07BFF8F2B

Q37976341-899DEFFB-DC91-4C62-AA56-E7665AA90BCE

Q37976341-AD624B86-2E30-496E-A248-8A92520568D1

P2860

Q37976341-00C92DB7-0DA5-44C4-8EA0-C3948A049AFF

Q37976341-021A1B5F-EE1B-45AA-9F25-C9ACEF982469

Q37976341-06157DB8-B225-4A78-8402-57091471E144

Q37976341-06F73F74-FF80-43A3-8227-F73EFC701225

Q37976341-09BADF83-C77C-488C-95AB-5A66870C8E55

Q37976341-0F3745E3-D463-4C9C-8264-0353880E2AD6

Q37976341-122C226C-54DE-4DAE-8434-6B74ACCE1766

Q37976341-122F518E-69AC-46E5-9672-6705B2369E36

Q37976341-15FB9CD6-69CC-4CFF-920B-9C3907D569F1

Q37976341-1662EDEC-8306-41DC-96A1-3DF34DE3AEAA

P2888

Q37976341-0201635C-2086-4765-B60E-28153B76C2AE

P304

Q37976341-E4664B4D-035D-472E-A501-FF71CDAC4068

P31

Q37976341-70B6EFAC-2F64-44DB-B92E-C828A5461AAD

P356

Q37976341-45BA9F9B-1ECC-4292-BC3A-71C33485B970

P407

Q37976341-41433BF0-6B45-4EEE-8AC7-B5065A4965ED

P433

Q37976341-35AE2C72-FA1A-4D1D-B606-A18CE9A45B05

P478

Q37976341-1B34D74E-AB90-4891-865C-7AABEF8A61BD

P50

Q37976341-BDE24539-94AF-4377-99D8-B8E29549EB06

Q37976341-C061448D-4420-44D5-B26F-F532CA336992

P577

Q37976341-983CEAA9-6086-4AEC-A311-AEB066AA1755

P5875

Q37976341-1EF85CB2-F95E-4C72-BC34-6750C6E28F44

P698

Q37976341-7E76B8F2-60E8-49C0-9936-41156C495B79

P356

NRGASTRO.2011.273

P1433

Nature Reviews Gastroenterology & Hepatology

P1476

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach

@en

P2093

Alberto Villani

http://www.w3.org/2001/XMLSchema#string

Ariel E Feldstein

http://www.w3.org/2001/XMLSchema#string

Massimiliano Raponi

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and Trends in Obesity Among US Adults, 1999-2000

Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease

Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

P2888

nrgastro.2011.273

P304

152-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRGASTRO.2011.273

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221751838

http://www.w3.org/2001/XMLSchema#string

P698

22249728

http://www.w3.org/2001/XMLSchema#string